Drospirenone 4 mg in a 24 + 4 regimen in women with contraindications to oestrogen use for contraception: bleeding patterns according to previous menstrual characteristics-Reference-Cited by-同舟云学术

Drospirenone 4 mg in a 24 + 4 regimen in women with contraindications to oestrogen use for contraception: bleeding patterns according to previous menstrual characteristics

Published:2022-11-21 Issue:3 Volume:307 Page:873-879
ISSN:1432-0711
Container-title:Archives of Gynecology and Obstetrics
language:en
Short-container-title:Arch Gynecol Obstet

Author:

Grandi Giovanni^ORCID,Del Savio Maria Chiara,Melotti Chiara,Facchinetti Fabio

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00404-022-06853-1.pdf

Reference17 articles.

1. World Health Organization (2015) Medical eligibility criteria for contraceptive use, 5th edn. WHO, Geneva

2. Grandi G, Cagnacci A, Volpe A (2014) Pharmacokinetic evaluation of desogestrel as a female contraceptive. Expert Opin Drug Metab Toxicol 10(1):1–10

3. Kovacs G (1996) Progestogen-only pills and bleeding disturbances. Hum Reprod 11(2):20–23

4. Del Savio MC, De Fata R, Facchinetti F, Grandi G (2020) Drospirenone 4 mg-only pill (DOP) in 24+4 regimen: a new option for oral contraception. Expert Rev Clin Pharmacol 13(7):685–694

5. Palacios S, Regidor PA, Colli E, Skouby SO, Apter D, Roemer T, Egarter C, Nappi RE, Skřivánek A, Jakimiuk AJ, Weyers S, Ács N, Elia D, Gemzell Danielsson K, Bitzer J (2020) Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature. Eur J Contracept Reprod Health Care 25(3):221–227

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new progestin-only pill (POP): the impact of drospirenone-only pill 4 mg 24 + 4 on coagulation markers and bleeding patterns;The European Journal of Contraception & Reproductive Health Care;2023-11-02